EyePoint Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
EyePoint Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • EyePoint Pharmaceuticals, Inc. Current Ratio for the quarter ending June 30, 2024 was 440 %, a 6.99% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 440 +28.7 +6.99% Jun 30, 2024
Q1 2024 379 -175 -31.6% Mar 31, 2024
Q4 2023 362 -227 -38.6% Dec 31, 2023
Q3 2023 327 -367 -52.9% Sep 30, 2023
Q2 2023 411 -328 -44.4% Jun 30, 2023
Q1 2023 554 -264 -32.3% Mar 31, 2023
Q4 2022 589 -353 -37.5% Dec 31, 2022
Q3 2022 694 -106 -13.3% Sep 30, 2022
Q2 2022 739 +5.23 +0.71% Jun 30, 2022
Q1 2022 818 +208 +34.2% Mar 31, 2022
Q4 2021 943 +523 +125% Dec 31, 2021
Q3 2021 800 +397 +98.3% Sep 30, 2021
Q2 2021 734 +307 +71.9% Jun 30, 2021
Q1 2021 610 +150 +32.7% Mar 31, 2021
Q4 2020 420 +78 +22.8% Dec 31, 2020
Q3 2020 403 +103 +34.5% Sep 30, 2020
Q2 2020 427 +159 +59.4% Jun 30, 2020
Q1 2020 459 +245 +114% Mar 31, 2020
Q4 2019 342 +154 +82.1% Dec 31, 2019
Q3 2019 300 +115 +61.9% Sep 30, 2019
Q2 2019 268 +105 +64.3% Jun 30, 2019
Q1 2019 215 +38.7 +22% Mar 31, 2019
Q4 2018 188 -134 -41.7% Dec 31, 2018
Q3 2018 185 -151 -44.8% Sep 30, 2018
Q2 2018 163 -218 -57.3% Jun 30, 2018
Q1 2018 176 -271 -60.6% Mar 31, 2018
Q4 2017 322 -242 -43% Dec 31, 2017
Q3 2017 336 -280 -45.5% Sep 30, 2017
Q2 2017 381 -317 -45.4% Jun 30, 2017
Q1 2017 447 -336 -43% Mar 31, 2017
Q4 2016 564 -319 -36.1% Dec 31, 2016
Q3 2016 616 -542 -46.8% Sep 30, 2016
Q2 2016 698 -690 -49.7% Jun 30, 2016
Q1 2016 783 -678 -46.4% Mar 31, 2016
Q4 2015 884 -450 -33.7% Dec 31, 2015
Q3 2015 1.16K +33 +2.94% Sep 30, 2015
Q2 2015 1.39K +558 +67.2% Jun 30, 2015
Q1 2015 1.46K +788 +117% Mar 31, 2015
Q4 2014 1.33K +751 +129% Dec 31, 2014
Q3 2014 1.12K +543 +93.3% Sep 30, 2014
Q2 2014 830 +281 +51.1% Jun 30, 2014
Q1 2014 673 +87 +14.8% Mar 31, 2014
Q4 2013 582 -32.8 -5.34% Dec 31, 2013
Q3 2013 582 -30.1 -4.92% Sep 30, 2013
Q2 2013 550 -63.6 -10.4% Jun 30, 2013
Q1 2013 586 -13.1 -2.19% Mar 31, 2013
Q4 2012 615 Dec 31, 2012
Q3 2012 612 Sep 30, 2012
Q2 2012 613 Jun 30, 2012
Q1 2012 599 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.